Literature DB >> 6351409

Clinical management of respiratory disease in feedlot cattle.

C A Hjerpe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6351409     DOI: 10.1016/s0196-9846(17)30096-4

Source DB:  PubMed          Journal:  Vet Clin North Am Large Anim Pract        ISSN: 0196-9846


× No keyword cloud information.
  8 in total

1.  The pattern of fatal fibrinous pneumonia (shipping fever) affecting calves in a large feedlot in Alberta (1985-1988).

Authors:  C S Ribble; A H Meek; G K Jim; P T Guichon
Journal:  Can Vet J       Date:  1995-12       Impact factor: 1.008

2.  Vaccination studies against experimental bovine Pasteurella pneumonia.

Authors:  M A Cardella; M A Adviento; R M Nervig
Journal:  Can J Vet Res       Date:  1987-04       Impact factor: 1.310

3.  Clinical and pathological evaluation of sulbactam/ampicillin for treatment of experimental bovine pneumonic pasteurellosis.

Authors:  G A Gifford; A A Potter; L A Babiuk
Journal:  Can Vet J       Date:  1988-02       Impact factor: 1.008

4.  A comparison of trimethoprim-sulfadoxine and ceftiofur sodium for the treatment of respiratory disease in feedlot calves.

Authors:  G K Jim; C W Booker; P T Guichon
Journal:  Can Vet J       Date:  1992-04       Impact factor: 1.008

5.  Morphological study of bacterial pneumonia of feedlot cattle: Determination of age of lesions.

Authors:  P Y Daoust
Journal:  Can Vet J       Date:  1989-02       Impact factor: 1.008

6.  A review of morbidity and mortality rates and disease occurrence in north american feedlot cattle.

Authors:  A P Kelly; E D Janzen
Journal:  Can Vet J       Date:  1986-12       Impact factor: 1.008

Review 7.  Pathogenesis and pathology of bovine pneumonia.

Authors:  Roger J Panciera; Anthony W Confer
Journal:  Vet Clin North Am Food Anim Pract       Date:  2010-07       Impact factor: 3.357

Review 8.  Immunology and prevention of infection in feedlot cattle.

Authors:  J A Roth; L J Perino
Journal:  Vet Clin North Am Food Anim Pract       Date:  1998-07       Impact factor: 3.357

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.